These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 21602507)
1. Rectal use of gadopentetate dimeglumine for anastomotic leak evaluation in patients with sensitivity to iodinated contrast media. Bartolotta RJ; Margulis AR Radiology; 2011 Jun; 259(3):923. PubMed ID: 21602507 [No Abstract] [Full Text] [Related]
2. Oral use of gadopentetate dimeglumine for anastomotic leak in patients with iodine sensitivity. Margulis AR; Auh YH; Gagner M Radiology; 2004 Sep; 232(3):937. PubMed ID: 15333806 [No Abstract] [Full Text] [Related]
3. [Recommendations of the European Society of Urogenital Radiology on the use of contrast media and the opportunity to use paramagnetic contrast in patients allergic to iodinated contrast media treated with endourology]. Fariña LA; Alonso MV Actas Urol Esp; 2002; 26(10):820. PubMed ID: 12645382 [No Abstract] [Full Text] [Related]
4. Acute adverse reactions to radiographic iodinated and gadolinium-based contrast media: incidence, risk factors and premedication: from published evidence to a practical approach. Tonolini M; Bianco R Clin Ter; 2011; 162(6):591-4. PubMed ID: 22262334 [TBL] [Abstract][Full Text] [Related]
6. [Allergy to radiographic contrast media]. Vionnet J; Petitpierre S; Fumeaux A; Meuli R; Spertini F; Comte D Rev Med Suisse; 2013 Apr; 9(382):812-8. PubMed ID: 23667970 [TBL] [Abstract][Full Text] [Related]
7. Adverse reactions to iodinated contrast media: Safety of a study protocol that includes fast full-dose parenteral challenge tests searching for an alternative contrast media. Vega F; Múgica MV; Bazire R; Argíz L; Belver MT; Friera A; Blanco C Clin Exp Allergy; 2020 Feb; 50(2):271-274. PubMed ID: 31631431 [No Abstract] [Full Text] [Related]
8. A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities. Kuwatsuru R; Takahashi S; Umeoka S; Sugihara R; Zeng M; Huan Y; Peng W; Ma L; Guo L; Teng G; Yao W; Tozaki M; Endo M; Kaji S; Ro T; Tae Hahn S; Chul Kang B; Nishimura H; Sugawara Y; Katakami N; Breuer J; Aitoku Y J Magn Reson Imaging; 2015 Feb; 41(2):404-13. PubMed ID: 24692302 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study. Heinrich MC; Kuhlmann MK; Kohlbacher S; Scheer M; Grgic A; Heckmann MB; Uder M Radiology; 2007 Feb; 242(2):425-34. PubMed ID: 17179401 [TBL] [Abstract][Full Text] [Related]
10. [Hepatic chemoembolization in a patient allergic to iodinated contrast media: the use of Gd-DTPA]. Balestreri L; Morassut S Radiol Med; 1999 Sep; 98(3):208-9. PubMed ID: 10575459 [No Abstract] [Full Text] [Related]
11. Allergological workup with half-dose challenge in iodinated contrast media hypersensitivity. Soria A; Masson N; Vial-Dupuy A; Gaouar H; Amsler E; Chollet-Martin S; Nicaise-Roland P; Autegarden JE; Barbaud A Allergy; 2019 Feb; 74(2):414-417. PubMed ID: 30353926 [No Abstract] [Full Text] [Related]
12. Preventing recurrent hypersensitivity reactions to iodinated contrast media. Teoh WC Ann Acad Med Singap; 2023 Mar; 52(3):114-115. PubMed ID: 38904488 [No Abstract] [Full Text] [Related]
13. Gadodiamide as an alternative contrast medium in cerebral angiography in a patient with sensitivity to iodinated contrast medium. Arat A; Cekirge HS; Saatci I Neuroradiology; 2000 Jan; 42(1):34-7; discussion 37-9. PubMed ID: 10663467 [TBL] [Abstract][Full Text] [Related]
15. Patients with a history of hypersensitivity reaction to iodinated contrast medium and given iodinated contrast during an interventional pain procedure. Benzon HT; Schechtman J; Zheng SC; Katz JA; Patel A; Nagpal G; Liu BP Reg Anesth Pain Med; 2019 Jan; 44(1):118-121. PubMed ID: 30640663 [TBL] [Abstract][Full Text] [Related]
16. Clinical safety of gadopentetate dimeglumine. Nelson KL; Gifford LM; Lauber-Huber C; Gross CA; Lasser TA Radiology; 1995 Aug; 196(2):439-43. PubMed ID: 7617858 [TBL] [Abstract][Full Text] [Related]
17. Reducing the risk of iodine-based and MRI contrast media administration: recommendation for a questionnaire at the time of booking. Morcos SK; Bellin MF; Thomsen HS; Almén T; Aspelin P; Heinz-Peer G; Jakobsen JA; Liss P; Oyen R; Stacul F; van der Molen AJ; Webb JA; Eur J Radiol; 2008 May; 66(2):225-9. PubMed ID: 18342469 [TBL] [Abstract][Full Text] [Related]
18. Use of Magnetic Resonance Imaging With Hepatobiliary-Specific Contrast Agent for Precise Localization of a Bile Duct Leak. Muir A; Otero H; Blinman T; Wen J J Pediatr Gastroenterol Nutr; 2016 Sep; 63(3):e36. PubMed ID: 27548252 [No Abstract] [Full Text] [Related]
19. Cardiac arrest caused by IV gadopentetate dimeglumine. Unal O; Arslan H AJR Am J Roentgenol; 1999 Apr; 172(4):1141. PubMed ID: 10587169 [No Abstract] [Full Text] [Related]
20. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study. Cheong BY; Duran C; Preventza OA; Muthupillai R AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]